3KWW
Crystal structure of the 'restriction triad' mutant of HLA B*3508, beta-2-microglobulin and EBV peptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX1 |
Synchrotron site | Australian Synchrotron |
Beamline | MX1 |
Temperature [K] | 298 |
Collection date | 2008-05-12 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 50.972, 81.454, 110.380 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 33.670 - 2.180 |
R-factor | 0.188 |
Rwork | 0.186 |
R-free | 0.25100 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1zhl |
RMSD bond length | 0.007 |
RMSD bond angle | 1.040 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.260 |
High resolution limit [Å] | 2.180 | 2.180 |
Rmerge | 0.057 | |
Number of reflections | 24588 | |
<I/σ(I)> | 16.7 | 3.8 |
Completeness [%] | 99.4 | 99.9 |
Redundancy | 3.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 7.6 | 298 | 0.1M cacodlyate, 0.2M ammonium acetate, 18% PEG3350, pH 7.6, vapor diffusion, temperature 298K |